Applied Neuroscience into ADHD, sleep and Depression.
 

 

Research Institute Brainclinics was founded in 2001 as an independent research institute, specialised in advancing the understanding of psychiatric disorders through brain imaging (QEEG, ERPs), chronobiology and sleep, Research Domain Criteria (RDoC), which knowledge should aid in a future of personalised medicine in mental health. Brainclinics is further specialised in the development and application of neuromodulation techniques such as neurofeedback in the treatment of ADHD and magnetic brain stimulation (rTMS) in the treatment of depression and OCD.

Under the same name, Psychology Practice Bainclinics was founded in 2006. In this clinic new innovative treatments (neuromodulation techniques) were pioneered such as rTMS (Brain stimulation) in the treatment of depression (since 2006), OCD and Neurofeedback in the treatment of ADHD. In 2015 this clinic was acquired by the neuroCare Group and the protocols and assessments developed here form the basis for all neuroCare Clinics worldwide and more information can be found on the neuroCare website.

 

 

For the website from Psychology Practice Brainclinics / neuroCare Group on rTMS therapy (brain stimulation) in depression and Neurofeedback treatment in ADHD, also click here.


In order to provide you with appropriate information, you can choose from the following options (see tabs at the top of this page): 

 

Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen Research Institute

Are you looking for more scientific background on neuromodulation techniques such as rTMS and Neurofeedback or quantitative EEG (QEEG), or do you want to know more about our ongoing studies (iSPOT with ADHD or depression, or sleep studies), look at our research institute.

 

Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen EEG Support and neurosupplies 

As professional looking  for advice and support on equipment, products and supplies for your QEEG / EEG lab, rTMS or neurofeedback? Look at EEG Support and Neuro Supplies

 

Psychologenpraktijk Brainclinics: Behandeling en therapie van ADHD (neurofeedback), Depressie (rTMS) en slaapproblemen Community

In the Brainclinics community you can register yourself and become a member and thereby gain access to our many scientific publications, powerpoint presentation and other educational materials.


 Education for professionals

Are you, as a professional, looking for training in the field of neurofeedback, rTMS, QEEG or sleep and chronobiology, look at Brainclinics Education / neuroCademy

Also make sure to follow us on Twitter @Brainclinics or @neuroClinics

 

 

 

The Brainclinics research-team at the Biological Psychiatry conference in New York (2018), from left to right: Nikita van der Vinne, Hanneke van Dijk, Sebastian Olbrich, Martijn Arns, Madelon Vollebregt, Noralie Krepel & Tabitha Iseger.

 

 

 

BRAINCLINICS NEWS

 

Brain activity predicts response to Ritalin in ADHD
30-06-2018
Nijmegen, July 3rd, 2018 – Today results from the large multicenter iSPOT-A study were published in European Neuropsychopharmacology, demonstrating that brain activity can assist in predicting response to Ritalin in male adolescents with ADHD. In addition, this study clearly demonstrated gender differences in brain activity, where brain activity only predicted Ritalin response in males and not in females with ADHD. No differences in brain activity were found between children with and without ADHD, further demonstrating the value of brain imaging in prognosis rather than diagnosis.


Meta-analysis confirms sustained effects of neurofeedback
16-02-2018
Nijmegen, February 16th, 2018 - An international group of researchers conducted a meta-analysis that systematically looked at all available studies and found that after an intensive course of neurofeedback, the clinical benefit of neurofeedback on ADHD symptoms was maintained over a 6-month follow-up period (without treatment). At follow-up the effects of neurofeedback were not inferior to active treatments such as medication, whereas benefits for non-active control groups (such as cognitive training) were no longer present at follow-up. These results have now been published in the scientific journal European Child & Adolescent Psychiatry.